183 related articles for article (PubMed ID: 12030965)
1. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
[TBL] [Abstract][Full Text] [Related]
3. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Sandström G; Kalfas S
J Periodontal Res; 2000 Apr; 35(2):85-92. PubMed ID: 10863962
[TBL] [Abstract][Full Text] [Related]
4. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Kalfas S
APMIS; 2002 Dec; 110(12):857-62. PubMed ID: 12645663
[TBL] [Abstract][Full Text] [Related]
5. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans.
Claesson R; Johansson A; Belibasakis G; Hänström L; Kalfas S
J Periodontal Res; 2002 Oct; 37(5):353-9. PubMed ID: 12366858
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
Johansson A; Hänström L; Kalfas S
Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
[TBL] [Abstract][Full Text] [Related]
7. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
Kachlany SC
J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
[TBL] [Abstract][Full Text] [Related]
8. Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis?
Guthmiller JM; Lally ET; Korostoff J
Crit Rev Oral Biol Med; 2001; 12(2):116-24. PubMed ID: 11345522
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis.
Haraszthy VI; Hariharan G; Tinoco EM; Cortelli JR; Lally ET; Davis E; Zambon JJ
J Periodontol; 2000 Jun; 71(6):912-22. PubMed ID: 10914794
[TBL] [Abstract][Full Text] [Related]
10. The relationships between leukotoxin production, growth rate and the bicarbonate concentration in a toxin-production-variable strain of Actinobacillus actinomycetemcomitans.
Ohta H; Miyagi A; Kato K; Fukui K
Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():963-970. PubMed ID: 8936323
[TBL] [Abstract][Full Text] [Related]
11. Serum-mediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Kalfas S
Eur J Oral Sci; 2003 Jun; 111(3):209-15. PubMed ID: 12786951
[TBL] [Abstract][Full Text] [Related]
12. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure.
Bueno LC; Mayer MP; DiRienzo JM
J Periodontol; 1998 Sep; 69(9):998-1007. PubMed ID: 9776028
[TBL] [Abstract][Full Text] [Related]
13. cis Elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans.
Kolodrubetz D; Spitznagel J; Wang B; Phillips LH; Jacobs C; Kraig E
Infect Immun; 1996 Sep; 64(9):3451-60. PubMed ID: 8751884
[TBL] [Abstract][Full Text] [Related]
14. Lytic effects of Actinobacillus actinomycetemcomitans leukotoxin on human neutrophil cytoplasts.
Iwase M; Korchak HM; Lally ET; Berthold P; Taichman NS
J Leukoc Biol; 1992 Aug; 52(2):224-7. PubMed ID: 1506779
[TBL] [Abstract][Full Text] [Related]
15. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes.
Mangan DF; Taichman NS; Lally ET; Wahl SM
Infect Immun; 1991 Sep; 59(9):3267-72. PubMed ID: 1879940
[TBL] [Abstract][Full Text] [Related]
16. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity.
Johansson A; Sandström G; Claesson R; Hänström L; Kalfas S
Eur J Oral Sci; 2000 Apr; 108(2):136-46. PubMed ID: 10768727
[TBL] [Abstract][Full Text] [Related]
17. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
18. A quinol peroxidase inhibitor prevents secretion of a leukotoxin from Aggregatibacter actinomycetemcomitans.
Takashima E; Yamada H; Yajima A; Shiomi K; Omura S; Kiyoshi K
J Periodontal Res; 2010 Feb; 45(1):123-8. PubMed ID: 19602106
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Chang EH; Brown AC
J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
[TBL] [Abstract][Full Text] [Related]
20. The regulatory effect of fermentable sugar levels on the production of leukotoxin by Actinobacillus actinomycetemcomitans.
Mizoguchi K; Ohta H; Miyagi A; Kurihara H; Takashiba S; Kato K; Murayama Y; Fukui K
FEMS Microbiol Lett; 1997 Jan; 146(1):161-6. PubMed ID: 8997720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
